Assessment and treatment of diabetic foot ulcer

被引:104
作者
Fard, A. Shojaie
Esmaelzadeh, M.
Larijani, B.
机构
[1] Univ Tehran Med Sci, Dept Surg, Shariati Hosp, Tehran, Iran
[2] Univ Tehran Med Sci, Dept Endocrinol, Shariati Hosp, Tehran, Iran
关键词
D O I
10.1111/j.1742-1241.2007.01534.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background and objectives: Foot ulcers are one of the main complications in diabetes mellitus, with a 15% lifetime risk in all diabetic patients. The rate of lower extremity amputation among diabetic patients is 17-40 times higher than in non-diabetics. A critical triad of neuropathy, minor foot trauma and foot deformity was found in > 63% of diabetic foot ulcers (DFU). Peripheral vascular disease (PVD) has been identified in 30% of foot ulcers. We present a comprehensive assessment and the treatment of DFUs. We also want to notify physicians not to ignore foot assessment and examinations in patients with diabetes. Methods: We conducted this study on DFU on the basis of: pathogenesis and risk factors, assessment and physical examination, paraclinic assessment, treatment, cost and mortality and prevention. Results and findings: Approximately 20% of hospital admissions among diabetic patients are the result of foot problems. Diabetic foot assessment should include dermatological, vascular, neurological and musculoskeletal systems. There are three basic treatments for management of DFU: (i) debridement; (ii) antibiotics and (iii) revascularization. The cost to treat one simple ulcer is $5000 to $8000. Conclusion: Awareness of physicians about foot problems in diabetic patients, clinical examination and paraclinical assessment, regular foot examination, patient education, simple hygienic practices and provision of appropriate footwear combined with prompt treatment of minor injuries can decrease ulcer occurrence by 50%.
引用
收藏
页码:1931 / 1938
页数:8
相关论文
共 90 条
[1]
LONG-TERM PROGNOSIS FOR DIABETIC-PATIENTS WITH FOOT ULCERS [J].
APELQVIST, J ;
LARSSON, J ;
AGARDH, CD .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (06) :485-491
[2]
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy [J].
Barbano, RL ;
Herrmann, DN ;
Hart-Gouleau, S ;
Pennella-Vaughan, J ;
Lodewick, PA ;
Dworkin, RH .
ARCHIVES OF NEUROLOGY, 2004, 61 (06) :914-918
[3]
Becker W, 1999, Q J NUCL MED, V43, P9
[4]
Bonham P, 2001, J Wound Ostomy Continence Nurs, V28, P73, DOI 10.1067/mjw.2001.113243
[5]
Diabetic foot ulcers: A framework for prevention and care [J].
Boulton, AJ ;
Meneses, P ;
Ennis, WJ .
WOUND REPAIR AND REGENERATION, 1999, 7 (01) :7-16
[6]
The pathogenesis of diabetic foot problems: An overview [J].
Boulton, AJM .
DIABETIC MEDICINE, 1996, 13 :S12-S16
[7]
Boulton AJM, 2000, DIABETES-METAB RES, V16, pS2, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR105>3.0.CO
[8]
2-N
[9]
A prospective study of risk factors for diabetic foot ulcer - The Seattle diabetic foot study [J].
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Davignon, DR ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1036-1042
[10]
Protocol for treatment of diabetic foot ulcers [J].
Brem, H ;
Sheehan, P ;
Boulton, AJM .
AMERICAN JOURNAL OF SURGERY, 2004, 187 (5A) :1S-10S